ANIK - Anika Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5449.66M
Enterprise Value 3290.64M
Trailing P/E 24.91
Forward P/E 126.81
PEG Ratio (5 yr expected) 12.68
Price/Sales (ttm)4.26
Price/Book (mrq)1.71
Enterprise Value/Revenue 32.75
Enterprise Value/EBITDA 68.58

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 17.74%
Operating Margin (ttm)26.48%

Management Effectiveness

Return on Assets (ttm)6.22%
Return on Equity (ttm)7.10%

Income Statement

Revenue (ttm)105.56M
Revenue Per Share (ttm)7.31
Quarterly Revenue Growth (yoy)-8.30%
Gross Profit (ttm)74.28M
EBITDA 33.86M
Net Income Avi to Common (ttm)18.72M
Diluted EPS (ttm)1.27
Quarterly Earnings Growth (yoy)-4.30%

Balance Sheet

Total Cash (mrq)159.01M
Total Cash Per Share (mrq)11.19
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)17.98
Book Value Per Share (mrq)18.55

Cash Flow Statement

Operating Cash Flow (ttm)34.92M
Levered Free Cash Flow (ttm)33.13M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.55
52-Week Change 3-30.46%
S&P500 52-Week Change 38.62%
52 Week High 346.59
52 Week Low 328.54
50-Day Moving Average 330.69
200-Day Moving Average 334.69

Share Statistics

Avg Vol (3 month) 3161.48k
Avg Vol (10 day) 3119.73k
Shares Outstanding 514.21M
Float 13.66M
% Held by Insiders 13.86%
% Held by Institutions 191.91%
Shares Short (Mar 29, 2019) 42.57M
Short Ratio (Mar 29, 2019) 411.26
Short % of Float (Mar 29, 2019) 425.37%
Short % of Shares Outstanding (Mar 29, 2019) 418.05%
Shares Short (prior month Feb 28, 2019) 42.26M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A